Icyitegererezo cy'ubuntu cyo kurwanya gusaza 1094-61-7 Beta Nmn Nicotinamide Mononucleotide OEM 99% Nmn Powder
Dufite imashini zikora zigezweho cyane, injeniyeri n'abakozi bafite uburambe kandi babishoboye, duzwiho imicungire myiza ndetse n'itsinda ry'inzobere mu kugurisha mbere/nyuma yo kugurisha, dutanga ubufasha ku buntu ku bijyanye no kurwanya gusaza 1094-61-7 Beta Nmn Nicotinamide Mononucleotide OEM 99% Nmn Powder, Igitekerezo cyacu ni ubunyangamugayo, ubuhanga, ubw'ukuri no guhanga udushya. Dufashijwe n'ubufasha, tuzarushaho kunoza ibintu.
Dufite imashini zikora zigezweho cyane, injeniyeri n'abakozi bafite uburambe kandi babishoboye, duzwiho imicungire myiza ndetse tunafite itsinda ry'inzobere mu kugurisha mbere/nyuma yo kugurisha.Ubushinwa Nmn na Nicotinamide Mononucleotide, Ubwinshi bw'umusaruro, ubwiza bwo hejuru, gutanga ibicuruzwa ku gihe kandi unyuzwe ni ukuri. Twakira ibibazo byose n'ibitekerezo. Dutanga kandi serivisi z'ikigo—zikora nk'umukozi mu Bushinwa ku bakiriya bacu. Niba ushishikajwe n'ibicuruzwa byacu cyangwa ufite itegeko rya OEM ugomba gukora, ibuka kutwandikira ubu ngubu. Gukorana natwe bizagufasha kuzigama amafaranga n'igihe.
Vuba aha, hari inkuru nziza mu bijyanye na NMN - nyuma y’isuzuma rikomeye ryakozwe n’akanama k’abahanga k’ikigo gishinzwe ibiribwa n’imiti muri Amerika (FDA), ibikoresho fatizo bya NMN bya Shangke Biopharmaceutical (Shanghai) Co., Ltd. (byitwa "Shangke Bio") byemejwe na Leta Zunze Ubumwe za Amerika. Icyemezo cya FDA NDI cyemeza ko ibikoresho fatizo byayo bya NMN bishobora gukoreshwa ku mugaragaro mu gukora, kugurisha no kwamamaza inyongeramusaruro muri Leta Zunze Ubumwe za Amerika, kandi biboneka ku rubuga rwa interineti rwa FDA nk’ibikoresho fatizo bishya by’inyongeramusaruro, nimero 1247.
FDA NDI ni yo sisitemu y’ingenzi cyane yo kwemeza ibicuruzwa ku isoko rya Amerika. Kubona iyi yemeza ntibisobanura gusa ko umutekano n’ubwiza bw’ibicuruzwa bya Shangke Bio bizwi cyane, ahubwo binafasha iterambere rihoraho ry’inganda za NMN mu gihe kirekire.
| Izina ry'Ubutabire | β-Nicotinamide Mononucleotide |
| Amagambo asa | NICOTINAMIDE-1-IUM-1-BETA-D-RIBOFURANOSIDE 5′-FOSPHATE |
| Nimero ya CAS | 1094-61-7 |
| Uburemere bwa molekile | 334.22 |
| Formula ya Molecular | C11H15N2O8P |
| EINECS 号: | 214-136-5 |
| Aho gushonga | 166 °C (Ukuboza) |
| ubushyuhe bwo kubika. | -20°C |
| gushonga | DMSO (Ishyushye gake), Methanol (Gake), Amazi (Gake) |
| ifishi | Bikomeye |
| ibara | Kuva ku mweru kugeza ku muhondo |
| Merck | 13,6697 |
| BRN | 3570187 |
| Ituze: | Ifite imiterere y'izuba cyane |
| InChIKey | DAYLJWODMCOQEW-TURQNECASA-N |
| Ikintu cy'igerageza | Ibisobanuro |
| Isura | Ifu y'umweru kuva ku ibara ry'umweru kugeza ku ibara ry'umweru |
| Ingano ya sodiyumu | ≤1% |
| Agaciro ka pH (100mg/ml) | 2.0~4.0 |
| Ubwiza | ≥99.0% |
| Ibipimo by'amazi | ≤1% |
| Ibyuma biremereye | <10ppm |
| Arsenic | <0.5ppm |
| Umuyobozi | <0.5ppm |
| Mercure | <0.1ppm |
| Kadimu | <0.5ppm |
| Ibisigazwa by'imiti ishongesha | Ethanol≤1000ppm |
| Umubare wose w'udukoko two mu kirere | <750cfu/g |
| Umusemburo n'Ibihumyo | <25cfu/g |
| Igiteranyo cy'uruhu rw'inyuma | ≤0.92MPN/g |
| E. Coli | Ububi |
| Salmonella | Ububi |
| Staph. Aureus | Ububi |
| Isuzuma (rishingiye ku mazi adafite amazi) | ≥99.0% |
| Igipimo cyo kwibira | ≥95% |
| Ubucucike bw'umubyimba | Raporo kugira ngo ubone amakuru |
Pake:Icupa, agapfunyika ka aluminiyumu, 25kg/Ingoma ya Karito, cyangwa hakurikijwe ibyo umukiriya asabwa.
Imiterere y'ububiko:Bika mu bikoresho bikomeye kandi bidashobora koroha, kugira ngo bibikwe igihe kirekire, bika ahantu hashyushye cyane kuri 2 ~ 8°C cyangwa munsi yayo.
Nicotinamide Mononucleotide (NMN) ni verisiyo nshya ya vitamine B3, ikaba ari intambwe imwe ibanziriza NAD+ (Nicotinamide Adenine Dinucleotide). NMN ni yo mashini ya mbere ya NAD+ igarura uturemangingo yagaragaye ko ikora neza mu kugarura uturemangingo mu mubiri.
Nicotinamide Adenine Dinucleotide (NAD) ni imwe mu ngirabuzimafatizo z'ingenzi kandi zishimishije mu mubiri. Irakenewe ku bikorwa birenga 500 bya enzyme kandi igira uruhare runini mu kugenzura hafi ya byose by'ingenzi mu buzima (Ansari na Raghava, 2010). Ikirenze byose, ishobora gutuma tugira ubuzima bwiza kandi burambye.
Nicotinamide Adenine Dinucleotide (NAD) ibaho mu buryo bwayo bwa oxidized (NAD+) cyangwa mu buryo bwagabanutse (NADH), ibyo bikaba ari ibintu by'ingenzi bigize oxireductases nyinshi.
SyncoZyems ni yo ya mbere yabonye ikigo cy’ibikoresho fatizo cyemewe na FDA NDI NMN, ihagarariye umukozi wa FDA yemera NMN nk'ubwoko bushya bw'ibikoresho bushobora gutangira kwemerwa no kwemerwa nk'ibikoresho by'inyongeramusaruro muri Leta Zunze Ubumwe za Amerika. Dufite imashini zikora zigezweho cyane, injeniyeri n'abakozi b'inararibonye kandi babishoboye, sisitemu nziza zo gucunga neza ndetse n'itsinda ry'inzobere mu kugurisha mbere/nyuma yo kugurisha, icyitegererezo cy'ubuntu cyo kurwanya gusaza 1094-61-7 Beta Nmn Nicotinamide Mononucleotide OEM 99% Nmn Powder, Igitekerezo cyacu cyo gushyigikira ni ubunyangamugayo, ubukana, ukuri no guhanga udushya. Dufashijwemo n'ubufasha, tuzarushaho kunoza.
Urugero rw'ubuntu kuriUbushinwa Nmn na Nicotinamide Mononucleotide, Ubwinshi bw'umusaruro, ubwiza bwo hejuru, gutanga ibicuruzwa ku gihe kandi unyuzwe ni ukuri. Twakira ibibazo byose n'ibitekerezo. Dutanga kandi serivisi z'ikigo—zikora nk'umukozi mu Bushinwa ku bakiriya bacu. Niba ushishikajwe n'ibicuruzwa byacu cyangwa ufite itegeko rya OEM ugomba gukora, ibuka kutwandikira ubu ngubu. Gukorana natwe bizagufasha kuzigama amafaranga n'igihe.
